| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a1d4f91ec253d18f8f1567944da556c3 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-16134
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-507
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-1018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-42 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| filingDate |
2018-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_16dd705f8203e1b3e287923f086264b1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d9d98c59161f8c868ec3435c3d23559
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb8b14051b5439c371b2499609af9123
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0613a45890eedf1cdd00c41ff33e305
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d1558a92cdc72c768ea5f61a85a3676b |
| publicationDate |
2020-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20200060969-A |
| titleOfInvention |
Dosage Regimen For Treating Influenza Virus-Related Disease |
| abstract |
The present invention relates to a dosing regimen for the treatment of influenza virus diseases, and relates to a method for treating influenza virus related diseases by administering a mixed composition of monoclonal antibodies having neutralizing activity against influenza A virus. The treatment method according to the present invention allows the influenza A virus-related disease to be treated by intravenously administering a mixed composition of monoclonal antibodies having neutralizing activity against the influenza A virus. In addition, the treatment method according to the present invention may satisfy an unmet medical need for a biological therapeutic agent for an influenza virus-related disease. |
| priorityDate |
2018-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |